Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer − PORTEC-4a an international, randomised, phase 3 trial

Anne Sophie V.M. van den Heerik, Nanda Horeweg, Marie A.D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L.A. Koppe, Marlies E. Nowee, Henrike Westerveld, Maria A.A. de Jong, Filip Frühauf, Jeltsje S. Cnossen, Jan Willem M. Mens, Jannet C. Beukema, Cyrus Chargari, Charles Gillham, Dorine S.J. Tseng, Katrien Vandecasteele, Moritz Hamann, Mandy Kiderlen, Stephan Polterauer, Annette Staebler, Hans W. Nijman, Bastiaan G. Wortman, Stephanie M. De Boer, Karen W. Verhoeven-Adema, Remi A. Nout, Hein Putter, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Wilbert B. van den Hout

Open source

DOI: 10.1016/j.radonc.2026.111406
Published: 2026-04
Container: Radiotherapy and Oncology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.radonc.2026.111406,
  title = {Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer − PORTEC-4a an international, randomised, phase 3 trial},
  author = {Anne Sophie V.M. van den Heerik and Nanda Horeweg and Marie A.D. Haverkort and Nienke Kuijsters and Stefan Kommoss and Friederike L.A. Koppe and Marlies E. Nowee and Henrike Westerveld and Maria A.A. de Jong and Filip Frühauf and Jeltsje S. Cnossen and Jan Willem M. Mens and Jannet C. Beukema and Cyrus Chargari and Charles Gillham and Dorine S.J. Tseng and Katrien Vandecasteele and Moritz Hamann and Mandy Kiderlen and Stephan Polterauer and Annette Staebler and Hans W. Nijman and Bastiaan G. Wortman and Stephanie M. De Boer and Karen W. Verhoeven-Adema and Remi A. Nout and Hein Putter and Vincent T.H.B.M. Smit and Carien L. Creutzberg and Wilbert B. van den Hout},
  year = {2026},
  journal = {Radiotherapy and Oncology},
  doi = {10.1016/j.radonc.2026.111406},
  url = {https://doi.org/10.1016/j.radonc.2026.111406}
}

RIS

TY  - JOUR
TI  - Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer − PORTEC-4a an international, randomised, phase 3 trial
AU  - Anne Sophie V.M. van den Heerik
AU  - Nanda Horeweg
AU  - Marie A.D. Haverkort
AU  - Nienke Kuijsters
AU  - Stefan Kommoss
AU  - Friederike L.A. Koppe
AU  - Marlies E. Nowee
AU  - Henrike Westerveld
AU  - Maria A.A. de Jong
AU  - Filip Frühauf
AU  - Jeltsje S. Cnossen
AU  - Jan Willem M. Mens
AU  - Jannet C. Beukema
AU  - Cyrus Chargari
AU  - Charles Gillham
AU  - Dorine S.J. Tseng
AU  - Katrien Vandecasteele
AU  - Moritz Hamann
AU  - Mandy Kiderlen
AU  - Stephan Polterauer
AU  - Annette Staebler
AU  - Hans W. Nijman
AU  - Bastiaan G. Wortman
AU  - Stephanie M. De Boer
AU  - Karen W. Verhoeven-Adema
AU  - Remi A. Nout
AU  - Hein Putter
AU  - Vincent T.H.B.M. Smit
AU  - Carien L. Creutzberg
AU  - Wilbert B. van den Hout
PY  - 2026
JO  - Radiotherapy and Oncology
DO  - 10.1016/j.radonc.2026.111406
UR  - https://doi.org/10.1016/j.radonc.2026.111406
ER  -

APA

Heerik, A. S. V. V. D., Horeweg, N., Haverkort, M. A., Kuijsters, N., Kommoss, S., Koppe, F. L., Nowee, M. E., Westerveld, H., Jong, M. A. D., Frühauf, F., Cnossen, J. S., Mens, J. W. M., Beukema, J. C., Chargari, C., Gillham, C., Tseng, D. S., Vandecasteele, K., Hamann, M., Kiderlen, M., Polterauer, S., Staebler, A., Nijman, H. W., Wortman, B. G., Boer, S. M. D., Verhoeven-Adema, K. W., Nout, R. A., Putter, H., Smit, V. T., Creutzberg, C. L., & Hout, W. B. V. D. (2026). Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer − PORTEC-4a an international, randomised, phase 3 trial. Radiotherapy and Oncology. https://doi.org/10.1016/j.radonc.2026.111406

Source records

crossref · retrieved 2026-09-27T02:04:31.537Z